Abstract
Leukaemia niche impacts quiescence, however culturing patient derived samples ex vivo is technically challenging. Here, we present a protocol for in vitro co-culture of patient-derived-xenograft acute lymphoblastic leukaemia (PDX-ALL) cells with human mesenchymal stem cells (MSC). We describe steps for labeling PDX-ALL cells with CellTrace™ Violet dye to demonstrate MSC-primed PDX-ALL cycling. We then detail procedures to identify MSC-primed G0/quiescent PDX-ALL cells via Hoechst-33342 / Pyronin Y live cell cycle analysis.
| Original language | English |
|---|---|
| Article number | 103202 |
| Number of pages | 18 |
| Journal | STAR Protocols |
| Volume | 5 |
| Issue number | 3 |
| Early online date | 20 Jul 2024 |
| DOIs | |
| Publication status | Published - 20 Sept 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cell Differentiation
- Cell-based Assays
- Stem Cells
Fingerprint
Dive into the research topics of 'Protocol for in vitro co-culture, proliferation, and cell cycle analyses of patient-derived leukemia cells'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver